BioCentury | Oct 22, 2012
Company News

Amarantus BioSciences, Baystate Medical Center, University of Massachusetts neurology news

...The Pioneer Valley Life Sciences Institute's Center of Excellence in Apoptosis Research (CEAR) awarded Amarantus a translational research grant to...
...testing to treat Parkinson's disease (PD), traumatic brain injury (TBI) and ischemic heart disease. The Pioneer Valley Life Sciences Institute...
BioCentury | Mar 26, 2012
Company News

Cellceutix, Beth Israel Deaconess deal

...p53 in melanoma and RCC. Details were not disclosed. In December 2011, Cellceutix partnered with Pioneer Valley Life Sciences Institute...
BioCentury | Dec 19, 2011
Company News

Cellceutix, Pioneer Valley Life Sciences Institute deal

...information regarding Kevetrin to the pharma (see BioCentury, March 14). Cellceutix Corp. (OTCQB:CTIX), Beverly, Mass. Pioneer Valley Life Sciences Institute...
Items per page:
1 - 3 of 3
BioCentury | Oct 22, 2012
Company News

Amarantus BioSciences, Baystate Medical Center, University of Massachusetts neurology news

...The Pioneer Valley Life Sciences Institute's Center of Excellence in Apoptosis Research (CEAR) awarded Amarantus a translational research grant to...
...testing to treat Parkinson's disease (PD), traumatic brain injury (TBI) and ischemic heart disease. The Pioneer Valley Life Sciences Institute...
BioCentury | Mar 26, 2012
Company News

Cellceutix, Beth Israel Deaconess deal

...p53 in melanoma and RCC. Details were not disclosed. In December 2011, Cellceutix partnered with Pioneer Valley Life Sciences Institute...
BioCentury | Dec 19, 2011
Company News

Cellceutix, Pioneer Valley Life Sciences Institute deal

...information regarding Kevetrin to the pharma (see BioCentury, March 14). Cellceutix Corp. (OTCQB:CTIX), Beverly, Mass. Pioneer Valley Life Sciences Institute...
Items per page:
1 - 3 of 3